{"id":99690,"date":"2026-07-08T09:05:24","date_gmt":"2026-07-08T09:05:24","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/99690\/"},"modified":"2026-07-08T09:05:24","modified_gmt":"2026-07-08T09:05:24","slug":"roche-korea-successfully-concludes-next-bio-builder-program-for-pharmacy-students","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/99690\/","title":{"rendered":"Roche Korea Successfully Concludes ‘Next Bio Builder Program’ for Pharmacy Students"},"content":{"rendered":"

\n Industry Leaders Share Practical Career Insights
Biotech Asset Analysis and Pitch Simulation\n <\/p>\n

Roche Korea announced on July 7 that it held the ‘Next Bio Builder Program: Nucleate Playbook-Based Workshop’ for next-generation biohealth talent in collaboration with Nucleate Korea and the Korean Pharmaceutical Students Federation (KNAPS) on July 3.<\/p>\n

This workshop was organized to commemorate the publication of the Korean version of the ‘Partnering with Pharma: Entrepreneurial Scientist Playbook’, which is featured on Nucleate Global’s official channel. The aim was to introduce aspiring young talents, who will lead the future healthcare industry, to vivid entrepreneurial pathways and to demonstrate the open innovation process between real startups and global pharmaceutical companies.<\/p>\n

\t
\n\t\t\t
\n\t\t\t\t\"On
\n\t\t\t<\/a><\/p>\n

On the 3rd, Roche Korea held the ‘Next Bio Builder Program: Workshop Based on Nucleate Playbook’ for the next-generation biohealth talent together with Nucleate Korea and the Korean Network of Pharmacy Students (KNAPS). Roche Korea<\/p>\n

\t\t\t
\n\t\t\t\tView original image
\n\t\t\t<\/a><\/p>\n

First, the workshop presented a core overview of the playbook, which covers the entire process of partnering between global pharmaceutical companies and startups. There was also a session to share practical \u201cdomestic application strategies and on-site insights\u201d about how global business development (BD) strategies can be integrated into Korea\u2019s pharmaceutical and biotechnology ecosystem.<\/p>\n

A career talk session was also held, featuring industry veterans active in the bio startup ecosystem. The speakers\u2014Taehoe Heo, CEO of iLab; Jaewon Choi, Head of Business Development at Survivent Biologics; and Minji Kim, Co-MD of Nucleate Korea\u2014shared practical insights on essential competencies for aspiring entrepreneurs, the realistic pros and cons of the startup ecosystem, and the mindset required for attracting investment.<\/p>\n

During the hands-on mini-workshop, participants had the opportunity to design partnership strategies with global pharmaceutical companies from the perspective of early-stage bio startup founders. Using the Nucleate Playbook, the students closely analyzed hypothetical biotech assets, established open innovation strategies from the perspective of BD experts, and participated in a final pitch simulation to propose these strategies, thereby gaining practical experience.<\/p>\n

<\/p>\n

Hot Picks Today
\n
\n \""Unimaginable
\n “Unimaginable in Korea”: No Air Conditioning Despite 40\u00b0C Carriages… London’s ‘Gentleman\u2019s Country’ Endures Sweltering Subways
\n <\/a><\/p>\n

Izat Azem, General Manager of Roche Korea, stated, \u201cI hope this playbook and workshop serve as a practical opportunity for pharmacy students to broaden their horizons into the business sector,\u201d adding, \u201cWe will continue to contribute to nurturing domestic biopharmaceutical talent and the growth of the industry through various partnerships.\u201d<\/p>\n

<\/p>\n

This content was produced with the assistance of AI translation services.<\/p>\n

\u00a9 The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.<\/p>\n","protected":false},"excerpt":{"rendered":"Industry Leaders Share Practical Career InsightsBiotech Asset Analysis and Pitch Simulation Roche Korea announced on July 7 that…\n","protected":false},"author":2,"featured_media":99691,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[21679,22073,8960,1202,22072,69,134,3381,1220,22071],"class_list":["post-99690","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-economic","tag-issue","tag-korea","tag-news","tag-newspaper","tag-politics","tag-roche","tag-society","tag-south-korea","tag-the-asia-business-daily"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116883562462237732","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/99690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=99690"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/99690\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/99691"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=99690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=99690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=99690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}